SMITH PATRICK W 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-27 9:58 pm Purchase | 2024-12-26 | 13G | OncoCyte Corporation OCX | SMITH PATRICK W | 1,773,903 10.500% | 215,466 (+13.83%) | Filing |
| 2024-12-09 5:30 pm Purchase | 2024-12-05 | 13G | OncoCyte Corporation OCX | SMITH PATRICK W | 1,558,437 9.300% | 545,116 (+53.79%) | Filing |
| 2024-10-09 5:03 pm Purchase | 2024-10-02 | 13G | OncoCyte Corporation OCX | SMITH PATRICK W | 1,013,321 6.000% | 1,013,321 (New Position) | Filing |